Posted: Jul 15, 2020 at 11:16 am ET Goldman Sachs earnings in focus. Getty The shares gained ground Wednesday due to optimism about progress on a COVID-19 vaccine candidate despite mounting cases in the United States, while investors digested earnings reports and monitored tensions between the United States and China. …
Read More »Dow flirts with a level of 27,000, the S&P 500 erases 2020 losses in vaccine hopes, Goldman’s earnings
